Cardiology in H1 2024
CardiacWire
JUNE 30, 2024
TR Options – H1 brought the FDA approvals of Edwards’ EVOQUE transcatheter tricuspid valve replacement system and Abbott’s TriClip tricuspid edge-to-edge repair (TEER) system, giving US interventionalists the options to repair or replace the tricuspid valve for the first time.
Let's personalize your content